Tag: Vandier
OSE Immunotherapeutics announces the appointment of Alexis Vandier as Chief Executive Officer – 2022-07-13 18:00
Nantes, France – July 13, 2022, 6:00 p.m. – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) is pleased to announce the appointment of Alexis Vandier as Chief Executive Officer, effective…